Bookmark and Share

This article is in the news archive.

Asahi Kasei Pharma Open Innovation in 2022

Asahi Kasei Pharma is publicly calling for new proposals related to drug discovery research as part of its efforts for open innovation, to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes, and enterprises around the world. Proposals are solicited concerning new drug seeds (drug target and drug candidate) and technologies in the therapeutic fields of autoimmune disease, critical care medicine, neurodegenerative disease, pain and neuropathy, bone disease, and drug discovery platform technology. Submissions will be assessed for their potential for collaborative research. More info here

Deadline for applications: 28 February, 08:00

Posted on 14/02/2022

Further news

Go to the news index page.